MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$18,756,000
Net loss
-$18,317,000
Unrealized loss on
marketable securities
-$439,000
Interest income
$1,982,000
Loss from operations
-$20,299,000
Total operating
expenses
$20,299,000
Research and development
$13,390,000
General and
administrative
$6,909,000
Back